lobbying_activities: 3436225
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3436225 | 15b37df3-82ac-47d6-9e9a-f2daf02f5200 | Q3 | COREWELL HEALTH | 298455 | COREWELL HEALTH | 2025 | third_quarter | PHA | 340B - Reforms to protect the integrity of the program. PBM Reform/Oversight. Transparency and high costs associated with prescription drugs. | HOUSE OF REPRESENTATIVES,SENATE | 190000 | 0 | 0 | 2025-10-16T11:24:37-04:00 |